Beschreibung

Mood and anxiety score trajectories comparing the saffron-ashwagandha supplement group with control over the study period, suggesting improvements in emotional well-being.

Figure 2

Chart

Source Paper

Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to-Moderate Anxiety During the COVID-19 Lockdown.

Depression and anxiety (2024)

PMID: 40226680

DOI: 10.1155/2024/3661412

Cite This Figure

![Figure 2: Mood and anxiety score trajectories comparing the saffron-ashwagandha supplement group with control over the study period, suggesting improvements in emotional well-being.](https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11919007/bin/DA2024-3661412.002.jpg)

> Source: Cristina Pages-García et al. "Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to." *Depression and anxiety*, 2024. PMID: [40226680](https://pubmed.ncbi.nlm.nih.gov/40226680/)

<figure>
  <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11919007/bin/DA2024-3661412.002.jpg" alt="Mood and anxiety score trajectories comparing the saffron-ashwagandha supplement group with control over the study period, suggesting improvements in emotional well-being." />
  <figcaption>Figure 2. Mood and anxiety score trajectories comparing the saffron-ashwagandha supplement group with control over the study period, suggesting improvements in emotional well-being.<br>  Source: Cristina Pages-García et al. "Effectiveness of a Saffron and Withania Supplement on Mood in Women With Mild-to." <em>Depression and anxiety</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40226680/">40226680</a></figcaption>
</figure>

Beschreibung

Figure 2

Source Paper

Cite This Figure

Verwandte Evidenz